Selective APOE4 Degradation via Proteolysis Targeting Chimeras (PROTACs)
h-11795af0
## Mechanistic Overview
Selective APOE4 Degradation via Proteolysis Targeting Chimeras (PROTACs) starts from the claim that modulating APOE within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** The apolipoprotein E gene (APOE) exists in three major isoforms—APOE2, APOE3, and APOE4—differing by
Elo ratings (across arenas)
| Arena | Rating | RD | W-L-D | N |
|---|---|---|---|---|
| global | 1412 | ±140 | 5-5-1 | 11 |
| neurodegeneration | 1326 | ±193 | 1-3-0 | 4 |
Ancestry (oldest → this)
(no parents — root hypothesis)
Descendants
(no variants yet)